Annual CFO:
$179.55M+$642.40M(+138.79%)Summary
- As of today, ARWR annual cash from operations is $179.55 million, with the most recent change of +$642.40 million (+138.79%) on September 30, 2025.
- During the last 3 years, ARWR annual cash from operations has risen by +$315.68 million (+231.90%).
- ARWR annual cash from operations is now at all-time high.
Performance
ARWR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$20.49M+$170.21M(+113.69%)Summary
- As of today, ARWR quarterly cash from operations is $20.49 million, with the most recent change of +$170.21 million (+113.69%) on September 1, 2025.
- Over the past year, ARWR quarterly cash from operations has increased by +$157.71 million (+114.93%).
- ARWR quarterly cash from operations is now -95.55% below its all-time high of $460.05 million, reached on March 31, 2025.
Performance
ARWR Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$179.55M+$157.71M(+721.94%)Summary
- As of today, ARWR TTM cash from operations is $179.55 million, with the most recent change of +$157.71 million (+721.94%) on September 1, 2025.
- Over the past year, ARWR TTM cash from operations has increased by +$642.40 million (+138.79%).
- ARWR TTM cash from operations is now -2.68% below its all-time high of $184.49 million, reached on June 30, 2021.
Performance
ARWR TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ARWR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +138.8% | +114.9% | +138.8% |
| 3Y3 Years | +231.9% | +129.8% | +231.9% |
| 5Y5 Years | +288.2% | +288.9% | +288.2% |
ARWR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +138.8% | -95.5% | +113.5% | at high | +136.2% |
| 5Y | 5-Year | at high | +138.8% | -95.5% | +113.5% | -2.7% | +136.2% |
| All-Time | All-Time | at high | +138.8% | -95.5% | +113.5% | -2.7% | +136.2% |
ARWR Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | $179.55M(+138.8%) | - | - |
| Sep 2025 | - | $20.49M(+113.7%) | $179.55M(+721.9%) |
| Jun 2025 | - | -$149.72M(-132.5%) | $21.84M(-61.1%) |
| Mar 2025 | - | $460.05M(+404.1%) | $56.15M(+111.3%) |
| Dec 2024 | - | -$151.27M(-10.2%) | -$496.28M(-7.2%) |
| Sep 2024 | -$462.85M(-200.8%) | -$137.22M(-18.9%) | -$462.85M(-31.9%) |
| Jun 2024 | - | -$115.42M(-24.9%) | -$350.89M(-36.6%) |
| Mar 2024 | - | -$92.38M(+21.6%) | -$256.92M(-30.9%) |
| Dec 2023 | - | -$117.84M(-366.6%) | -$196.21M(-27.5%) |
| Sep 2023 | -$153.89M(-13.0%) | -$25.26M(-17.8%) | -$153.89M(+22.0%) |
| Jun 2023 | - | -$21.45M(+32.3%) | -$197.30M(+19.4%) |
| Mar 2023 | - | -$31.67M(+58.1%) | -$244.70M(-62.8%) |
| Dec 2022 | - | -$75.52M(-10.0%) | -$150.30M(-10.4%) |
| Sep 2022 | -$136.13M(-179.5%) | -$68.67M(+0.3%) | -$136.13M(-48.6%) |
| Jun 2022 | - | -$68.85M(-209.8%) | -$91.58M(-75.0%) |
| Mar 2022 | - | $62.73M(+202.3%) | -$52.34M(-135.2%) |
| Dec 2021 | - | -$61.35M(-154.4%) | $148.80M(-13.1%) |
| Sep 2021 | $171.22M(+279.5%) | -$24.12M(+18.6%) | $171.22M(-7.2%) |
| Jun 2021 | - | -$29.61M(-111.2%) | $184.49M(+2.1%) |
| Mar 2021 | - | $263.87M(+778.0%) | $180.67M(+263.1%) |
| Dec 2020 | - | -$38.92M(-258.7%) | -$110.78M(-16.1%) |
| Sep 2020 | -$95.39M(-155.1%) | -$10.85M(+67.5%) | -$95.39M(-34.9%) |
| Jun 2020 | - | -$33.43M(-21.2%) | -$70.73M(-164.1%) |
| Mar 2020 | - | -$27.58M(-17.2%) | -$26.78M(-42.6%) |
| Dec 2019 | - | -$23.53M(-270.4%) | -$18.78M(-110.9%) |
| Sep 2019 | $173.03M(+466.4%) | $13.81M(+31.2%) | $173.03M(+10.5%) |
| Jun 2019 | - | $10.53M(+153.7%) | $156.54M(+18.9%) |
| Mar 2019 | - | -$19.59M(-111.6%) | $131.61M(-3.1%) |
| Dec 2018 | - | $168.28M(+6378.6%) | $135.75M(+387.5%) |
| Sep 2018 | -$47.22M(-97.3%) | -$2.68M(+81.4%) | -$47.22M(+12.1%) |
| Jun 2018 | - | -$14.41M(+6.7%) | -$53.75M(-8.0%) |
| Mar 2018 | - | -$15.44M(-5.1%) | -$49.75M(-2.3%) |
| Dec 2017 | - | -$14.69M(-59.6%) | -$48.63M(-103.1%) |
| Sep 2017 | -$23.94M(+62.8%) | -$9.20M(+11.6%) | -$23.94M(+3.9%) |
| Jun 2017 | - | -$10.41M(+27.3%) | -$24.92M(+24.2%) |
| Mar 2017 | - | -$14.33M(-243.3%) | -$32.86M(+1.3%) |
| Dec 2016 | - | $10.00M(+198.2%) | -$33.28M(+48.3%) |
| Sep 2016 | -$64.43M(+1.9%) | -$10.18M(+44.5%) | -$64.43M(+2.8%) |
| Jun 2016 | - | -$18.35M(-24.4%) | -$66.27M(-8.6%) |
| Mar 2016 | - | -$14.75M(+30.3%) | -$61.03M(+2.6%) |
| Dec 2015 | - | -$21.15M(-75.9%) | -$62.66M(+4.6%) |
| Sep 2015 | -$65.71M(-85.5%) | -$12.02M(+8.4%) | -$65.71M(-1.7%) |
| Jun 2015 | - | -$13.12M(+19.9%) | -$64.61M(-5.5%) |
| Mar 2015 | - | -$16.37M(+32.4%) | -$61.27M(-16.5%) |
| Dec 2014 | - | -$24.20M(-121.6%) | -$52.59M(-48.5%) |
| Sep 2014 | -$35.42M(-86.1%) | -$10.92M(-11.7%) | -$35.42M(-18.5%) |
| Jun 2014 | - | -$9.78M(-27.0%) | -$29.89M(-17.5%) |
| Mar 2014 | - | -$7.70M(-9.6%) | -$25.45M(-14.5%) |
| Dec 2013 | - | -$7.02M(-30.2%) | -$22.22M(-16.7%) |
| Sep 2013 | -$19.03M(-24.1%) | -$5.39M(-1.1%) | -$19.03M(-4.4%) |
| Jun 2013 | - | -$5.33M(-19.4%) | -$18.23M(-8.6%) |
| Mar 2013 | - | -$4.47M(-16.4%) | -$16.78M(-1.9%) |
| Dec 2012 | - | -$3.84M(+16.4%) | -$16.47M(-7.4%) |
| Sep 2012 | -$15.34M | -$4.59M(-18.0%) | -$15.34M(-23.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | -$3.89M(+6.4%) | -$12.42M(-30.8%) |
| Mar 2012 | - | -$4.16M(-53.7%) | -$9.49M(-6.2%) |
| Dec 2011 | - | -$2.71M(-62.7%) | -$8.94M(-16.7%) |
| Sep 2011 | -$7.66M(+0.5%) | -$1.66M(-72.0%) | -$7.66M(+10.2%) |
| Jun 2011 | - | -$967.00K(+73.2%) | -$8.52M(+8.6%) |
| Mar 2011 | - | -$3.60M(-153.0%) | -$9.33M(-24.4%) |
| Dec 2010 | - | -$1.42M(+43.8%) | -$7.50M(+2.5%) |
| Sep 2010 | -$7.70M(+49.6%) | -$2.53M(-42.8%) | -$7.70M(-1.5%) |
| Jun 2010 | - | -$1.77M(+0.1%) | -$7.58M(-4.0%) |
| Mar 2010 | - | -$1.78M(-9.7%) | -$7.29M(+22.8%) |
| Dec 2009 | - | -$1.62M(+33.0%) | -$9.45M(+38.2%) |
| Sep 2009 | -$15.28M(+44.6%) | -$2.42M(-62.8%) | -$15.28M(+28.1%) |
| Jun 2009 | - | -$1.48M(+62.2%) | -$21.25M(+22.5%) |
| Mar 2009 | - | -$3.93M(+47.2%) | -$27.42M(+6.1%) |
| Dec 2008 | - | -$7.45M(+11.2%) | -$29.20M(-5.9%) |
| Sep 2008 | -$27.58M(-15.6%) | -$8.38M(-9.5%) | -$27.58M(-7.3%) |
| Jun 2008 | - | -$7.65M(-34.0%) | -$25.70M(-8.5%) |
| Mar 2008 | - | -$5.71M(+2.0%) | -$23.68M(+3.8%) |
| Dec 2007 | - | -$5.83M(+10.2%) | -$24.61M(-3.1%) |
| Sep 2007 | -$23.87M(-61.4%) | -$6.50M(-15.3%) | -$23.87M(-8.9%) |
| Jun 2007 | - | -$5.64M(+15.1%) | -$21.92M(-10.2%) |
| Mar 2007 | - | -$6.64M(-30.5%) | -$19.90M(-19.2%) |
| Dec 2006 | - | -$5.09M(-11.8%) | -$16.69M(-12.9%) |
| Sep 2006 | -$14.79M(-62.6%) | -$4.55M(-25.9%) | -$14.79M(-15.4%) |
| Jun 2006 | - | -$3.62M(-5.4%) | -$12.82M(-5.6%) |
| Mar 2006 | - | -$3.43M(-7.6%) | -$12.14M(-17.4%) |
| Dec 2005 | - | -$3.19M(-23.3%) | -$10.34M(-13.7%) |
| Sep 2005 | -$9.10M(-293.2%) | -$2.59M(+11.9%) | -$9.10M(-26.1%) |
| Jun 2005 | - | -$2.93M(-79.6%) | -$7.21M(-41.6%) |
| Mar 2005 | - | -$1.63M(+16.1%) | -$5.09M(-29.3%) |
| Dec 2004 | - | -$1.95M(-178.0%) | -$3.94M(-70.2%) |
| Sep 2004 | -$2.31M(-1368.5%) | -$700.00K(+14.2%) | -$2.31M(-35.3%) |
| Jun 2004 | - | -$815.40K(-70.3%) | -$1.71M(-89.5%) |
| Mar 2004 | - | -$478.80K(-49.5%) | -$902.80K(-95.5%) |
| Dec 2003 | - | -$320.20K(-232.5%) | -$461.90K(-193.1%) |
| Sep 2003 | -$157.60K(-49.0%) | -$96.30K(-1184.0%) | -$157.60K(-109.0%) |
| Jun 2003 | - | -$7500.00(+80.2%) | -$75.40K(+35.5%) |
| Mar 2003 | - | -$37.90K(-138.4%) | -$116.90K(-23.2%) |
| Dec 2002 | - | -$15.90K(-12.8%) | -$94.90K(+10.4%) |
| Sep 2002 | -$105.80K(-29.3%) | -$14.10K(+71.2%) | -$105.90K(+0.6%) |
| Jun 2002 | - | -$49.00K(-208.2%) | -$106.50K(-46.1%) |
| Mar 2002 | - | -$15.90K(+40.9%) | -$72.90K(+18.9%) |
| Dec 2001 | - | -$26.90K(-83.0%) | -$89.90K(-9.8%) |
| Sep 2001 | -$81.80K(-2.1%) | -$14.70K(+4.5%) | -$81.90K(+7.2%) |
| Jun 2001 | - | -$15.40K(+53.2%) | -$88.30K(+34.3%) |
| Mar 2001 | - | -$32.90K(-74.1%) | -$134.30K(-33.9%) |
| Dec 2000 | - | -$18.90K(+10.4%) | -$100.30K(-25.1%) |
| Sep 2000 | -$80.10K(-127.6%) | -$21.10K(+65.6%) | -$80.20K(+76.4%) |
| Jun 2000 | - | -$61.40K(-5681.8%) | -$339.90K(-538.6%) |
| Mar 2000 | - | $1100.00(-8.3%) | $77.50K(+1.4%) |
| Dec 1999 | - | $1200.00(+100.4%) | $76.40K(+1.6%) |
| Sep 1999 | -$35.20K(+23.6%) | -$280.80K(-178.9%) | $75.20K(-78.9%) |
| Jun 1999 | - | $356.00K | $356.00K |
| Sep 1998 | -$46.10K(-1102.2%) | - | - |
| Sep 1997 | $4600.00 | - | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of ARWR is $179.55M
What is the all-time high annual cash from operations for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual cash from operations is $179.55M
What is Arrowhead Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, ARWR annual cash from operations has changed by +$642.40M (+138.79%)
What is Arrowhead Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of ARWR is $20.49M
What is the all-time high quarterly cash from operations for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly cash from operations is $460.05M
What is Arrowhead Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, ARWR quarterly cash from operations has changed by +$157.71M (+114.93%)
What is Arrowhead Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of ARWR is $179.55M
What is the all-time high TTM cash from operations for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high TTM cash from operations is $184.49M
What is Arrowhead Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, ARWR TTM cash from operations has changed by +$642.40M (+138.79%)